FILE PHOTO: Mayor of London Sadiq Khan speaks during an interview with Reuters at an event to promote the start of London Tech Week, in London, Britain, June 10, 2019. REUTERS/Dylan Martinez/File Photo
LONDON (Reuters) - U.S. President Donald Trump once again criticized London Mayor Sadiq Khan on Saturday, saying he is a “disaster” and will “only get worse” after three people were slain in the city in less than 20 hours.
Trump retweeted a tweet by the right-wing commentator Katie Hopkins who called London “stab city” and said “this is Khan’s Londonistan,” a phrase used to describe the city’s failure to tackle Muslim extremists.
“LONDON needs a new mayor ASAP. Khan is a disaster - will only get worse!” Trump said on Twitter.
Trump called Khan, a Muslim of Pakistani heritage, a “stone-cold loser” earlier this month after the mayor criticized the British government for inviting Trump for a state visit and compared him to 20th century fascists.
Trump’s feud with Khan dates back several years. Khan has criticized Trump’s effort to ban travelers from Muslim countries, while the president has castigated the mayor for his handling of a 2017 terrorist attack on the London bridge that killed 11 people.
Reporting By Andrew MacAskill; Editing by Bill Trott
DUBAI (Reuters) - Iran on Saturday summoned the British ambassador to Tehran after London blamed it for attacks on oil tankers in the Gulf of Oman, the semi-official Students News Agency ISNA reported.
“During the meeting with Iran’s foreign ministry official, Iran strongly condemned the unfounded allegations and criticized Britain’s unacceptable stance regarding the attacks in the Gulf of Oman,” it said.
The ambassador was asked for an explanation and correction after Britain was the only nation to echo U.S. accusations, ISNA reported.
British Foreign Secretary Jeremy Hunt issued a statement on Friday blaming Iran and its Islamic Revolutionary Guard Corps for the attacks, saying no other state or non-state actor could have been responsible.
Iran has denied any involvement.
The attacks have raised fears of a confrontation in the vital oil shipping route of the Strait of Hormuz at a time of increased tension between Iran and the United States.
Writing by Parisa Hafezi; Editing by Hugh Lawson and Andrew Cawthorne
PARIS (Reuters) - A small congregation in white hard hats attended mass at Notre-Dame Cathedral in Paris on Saturday, the first service since fire devastated the Gothic landmark two months ago.
The Archbishop of Paris Michel Aupetit leads the first mass in a side chapel two months to the day after a devastating fire engulfed the Notre-Dame de Paris cathedral, in Paris, France June 15, 2019. Karine Perret/Pool via REUTERS
Church leaders are keen to show life goes on at the cathedral as donations for rebuilding trickle in.
Less than 10% of the 850 million euros ($953 million) pledged by billionaires, business leaders and others has been received so far, the French government said.
The mass, which commemorates the cathedral’s consecration as a place of worship, was held in a side-chapel left undamaged by the April 15 fire, with attendance limited to about 30 people wearing protective headgear.
Priests in ceremonial garb of white robes and yellow stoles briefly parted with their hard hats during the communion.
“It is with much emotion that we are here to celebrate the consecration of the cathedral,” said Paris’s archbishop Michel Aupetit, who led the service.
“It is a message of hope and thanks to all those who were moved by what happened to this cathedral,” he added, acknowledging afterwards it was “a bit strange” to celebrate mass with a helmet.
The service was broadcast live on a religious TV channel that showed poignant images of the blue sky through the collapsed roof and the black rubble still clogging the building.
On Friday, France’s Culture Minister Franck Riester said the cathedral was still in a fragile state, especially the vault.
The blaze caused the roof and spire of the architectural masterpiece to collapse, triggering worldwide sadness.
Among those who promised to donate to the rebuilding effort were luxury goods tycoons Bernard Arnault and François-Henri Pinault.
“There could be people who promised to donate then in the end did not,” Riester told France 2 television, without giving further details. “But more importantly, and this is normal, the donations will be paid as restoration work progresses.”
President Emmanuel Macron has set a target of five years for restoring the cathedral, though Riester was more cautious.
“The president was right to give a target, an ambition,” he said. “But obviously what matters in the end is the quality of the work. So it does not mean that work will be totally finished in exactly five years.”
PARIS (Reuters) - A small congregation wearing hard hats will attend mass at Notre-Dame Cathedral in Paris on Saturday, the first service to be held since fire devastated the Gothic landmark two months ago.
FILE PHOTO: A picture shows bells gathered during preliminary work at the Notre-Dame Cathedral one month after it sustained major fire damage in Paris, France May 15, 2019. Philippe Lopez/Pool via REUTERS
Church leaders are keen to show life goes on at the cathedral as donations to help rebuild it trickle in. Less than 10% of the 850 million euros pledged by billionaires, business leaders and others has been received so far, the French government said.
Saturday’s mass, which commemorates the cathedral’s consecration as a place of worship, is due to be held at 1600 GMT in a side-chapel, with attendance limited to about 30 people who will wear the protective headgear for safety reasons.
“It is a nice symbol. A very small group of people will attend and one can understand why as there are still major safety issues,” Culture Minister Franck Riester told Europe 1 radio.
He told France 2 television on Friday the cathedral was still “in a fragile state, namely the vault, which has not yet been secured. It can still collapse”.
The April 15 blaze caused the roof and spire of the architectural masterpiece to collapse, triggering a worldwide outpouring of sadness as well as the multi-million-euro pledges for reconstruction work.
Among the high-profile people who promised to donate to the rebuilding effort were luxury goods tycoons Bernard Arnault and François-Henri Pinault.
“There could be people who promised to donate then in the end did not,” Riester said, without giving further details. “But more importantly, and this is normal, the donations will be paid as restoration work progresses.”
French President Emmanuel Macron has set a target of five years for restoring the cathedral, though Riester was more cautious.
“The president was right to give a target, an ambition. But obviously what matters in the end is the quality of the work,” he said. “So it does not mean that work will be totally finished in exactly five years.”
The archbishop of Paris, Michel Aupetit will lead Saturday’s service, which will be broadcast live on a religious TV channel.
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann
(This June 10 story deletes paragraph 9 to clarify that retreatment with Polivy has not been studied.)
(Reuters) - The U.S. Food and Drug Administration on Monday granted earlier-than-expected approval to Roche Holding AG’s antibody- Polivy for treatment of patients with advanced lymphoma.
Polivy was approved in combination with Roche’s older drug Rituxan and a chemotherapy agent for adult patients with advanced diffuse large B-cell lymphoma (DLBCL) whose cancer has worsened despite at least two previous lines of therapy.
Antibody-drug conjugates are designed to deliver a toxic chemotherapy directly to tumors. Roche said the average U.S. list price for a four-month course of Polivy would be $90,000. Rituxan is priced at $39,500 for four months.
Wall Street analysts estimate Polivy sales at nearly $1 billion by 2024, according to IBES data from Refinitiv.
Side effects seen in studies of Polivy included low blood cell counts, nerve damage, fatigue and pneumonia, the FDA said in a statement.
Cell therapies Yescarta, from Gilead Sciences Inc and Kymriah, sold by Novartis AG, are also approved for patients with advanced DLBCL.
Dr. Matthew Matasar, a hematologist at New York’s Memorial Sloan Kettering Cancer Center who was involved in the development of Polivy, said the drug could be an option for some patients to try before determining whether they need to move on to CAR-T treatments.
Roche estimates that nearly 25,000 new cases of DLBCL, a type of non-Hodgkin’s lymphoma (NHL), will be diagnosed in the United States this year. NHL, which is one of the most common cancers, accounts for about 4% of all types of cancers in the United States, according to the American Cancer Society. Continued approval for the treatment may depend on data from a confirmatory trial, Roche said. The FDA’s accelerated approval program allows conditional approval of a medicine that fills an unmet medical need for a serious condition.
Reporting by Aakash Jagadeesh Babu in Bengaluru and Deena Beasley in Los Angeles; Editing by James Emmanuel and Lisa Shumaker
FILE PHOTO - Ada Colau, the Mayor of Barcelona, issues a statement in Barcelona, Spain, October 9, 2017. REUTERS/Gonzalo Fuentes
BARCELONA (Reuters) - Barcelona’s acting far-leftist mayor Ada Colau may win a second term in office on Saturday with the support of the Socialists and representatives backed by former French premier Manuel Valls - in a deal aimed at preventing a Catalan pro-independence leader taking the job.
Local elections in May produced a fragmented result in Spain’s second-largest city: Colau’s Barcelona en Comu (Barcelona in Common) and the separatist Esquerra Republicana de Catalunya (Catalonia’s Republican Left) parties each won 10 seats, while the Socialists got eight and Valls’ group took six.
City hall votes to pick a new mayor on Saturday. The winning candidate will need the support of 21 representatives.
The outcome has national importance because Spain’s acting Socialist Prime Minister Pedro Sanchez may need the support of Esquerra Republicana to be re-elected by parliament in the coming weeks.
Colau’s party said on Friday its members had voted in favor of her seeking a new term in a deal with the Catalan Socialist Party.
Valls, born in Barcelona to a Catalan father and Swiss-Italian mother, has said he would support Colau or Socialist candidate Jaume Collboni as mayor to avoid a secessionist taking the job.
But if no candidate wins the support of 21 representatives, Esquerra’s Ernest Maragall would take the job as his party won 5,000 more votes than Barcelona en Comu in the May election.
GENEVA/ZURICH (Reuters) - Hundreds of thousands of women across Switzerland held a strike on Friday to highlight their wealthy nation’s poor record on female rights, recreating the passion of the last such walkout 28 years ago.
In Zurich, the financial capital and the country’s biggest city, tens of thousands of protesters clogged the streets, blowing whistles and banging pots and pans. “Men, go do the ironing,” one sign read.
“It’s not just about wages. The equal opportunity is not there. At least for the next generation it needs to be there,” Zurich city councilwoman Karin Rykart said as hundreds of municipal workers and police officers demonstrated.
Despite its high quality of life, Switzerland lags other developed economies in female pay and workplace gender equality.
Friday’s event echoed a strike in 1991, five years before the Gender Equality Act came into force. That banned workplace discrimination and sexual harassment and protected women from bias or dismissal over pregnancy, marital status, or gender.
But more than 20 years later, women still earn less than men, face routine questioning of their competence, and encounter condescension on the job, they say.
Organisers say the strike draws attention to wages, violence against women, and the need for greater representation in positions of power and more equitable family policy.
Christine Lagarde, the first woman to lead the International Monetary Fund, joined in while addressing an event in Geneva.
Protesters carry banners and placards at a demonstration during a women's strike (Frauenstreik) in Zurich, Switzerland June 14, 2019. REUTERS/Arnd Wiegmann
“At this point in time if I were true to my colors I would actually turn my back to you and express in that way the fact that I am actually on strike - but you might be disappointed,” she said.
“So instead of this I am actually wearing this (lapel pin) out of solidarity with the Swiss women who claim equality in terms of salaries and a few other things.”
The SGB labor union federation estimated 100,000 people joined the strike by midday, with more participating from 3:24 p.m., when women technically work for free given wage discrimination.
“THINGS DIDN’T CHANGE”
Swiss women earn roughly 20% less than men. While that is an improvement from about a third less in 1991, the discrimination gap — meaning differences that cannot be explained by rank or role — has actually worsened since 2000, government data show.
On June 14, 1991, women blocked trams during a sit-in in the heart of Zurich’s financial district and gathered outside schools, hospitals and across cities with purple balloons and banners to demand equal pay for equal work.
That came a decade after basic gender equality was enshrined in the Swiss constitution and less than three months after women for the first time were allowed to participate in a regional vote in the canton of Appenzell Innerrhoden.
“We have realized that even after this first strike in 1991, things didn’t really change. Equality is enshrined in the constitution, but real, material, effective equality doesn’t exist for all women,” said organizer Tamara Knezevic, 24.
Slideshow (32 Images)
The World Economic Forum found Switzerland ranked 34th for economic participation and opportunity and 44th for wage equality in a 2018 study of 149 countries.
See Factbox on 9 leading Swiss women
Additional reporting by Denis Balibouse in Lausanne and Stephanie Nebehay in Geneva; Editing by Andrew Cawthorne and Raissa Kasolowsky
LONDON (Reuters) - The number of people to die from a listeria outbreak in British hospitals has risen to five from three, Public Health England (PHE) said on Friday.
The agency said that since the outbreak it had reviewed earlier cases and established that one other death had also been linked to the infection, which is thought to stem from sandwiches and salads. One patient who had been seriously ill has also since died, taking the number to five.
“To date, there have been no patients linked to this incident outside healthcare organizations, but we continue to investigate,” said PHE’s Nick Phin. “Swift action was taken to protect patients and any risk to the public is low.
Reporting by Kate Holton; editing by Stephen Addison
PARIS (Reuters) - France and Italy forged a military shipbuilding alliance on Friday, as state-controlled Naval Group and Fincantieri signed off on a 50-50 joint venture that will bid for Franco-Italian warship projects and sell to the world market.
FILE PHOTO: A sub-scale sized model of a Corvette by Fincantieri is displayed at Euronaval, the world naval defence exhibition in Le Bourget near Paris, France, October 23, 2018. REUTERS/Benoit Tessier/File Photo
The alliance reflects the two countries’ desire to fend off competition in naval shipbuilding from the likes of China, the United States and Russia.
It is targeting orders worth up to 5 billion euros ($5.63 billion) over the next decade. Naval Group said the joint venture aims to build 10-15 warships in that period, with synergies estimated at 10-15%.
“It is the product of a shared industrial ambition,” Herve Guillou, chief executive of Naval Group told reporters on a call.
“We are by far the two biggest naval shipbuilders in Europe, but we cannot remain competitive and maximize our resources if we rely only on our domestic markets.”
The joint venture does not entail a share swap between the two groups.
France and Italy first outlined plans to deepen naval shipbuilding cooperation in September 2017.
However, political and business relations between the two euro zone powerhouses have become increasingly fraught since then and uncertainty hangs over other deals.
Earlier this month, Fiat Chrysler withdrew its proposal for a 35 billion euro merger with Renault, with both the Italian-American carmaker and Rome blaming French government interference for the deal’s collapse.
Meanwhile, at France’s request, the European Union’s antitrust chief is examining Fincantieri’s purchase of a 50% stake in French shipbuilder Chantiers de l’Atlantique, formerly STX, a move which irritated Fincantieri and Rome.
Fincantieri top executives recently said they were confident of winning approval from Brussels, but that it could take some months.
The joint venture between Fincantieri and Naval Group, in which French defense company Thales has a 35% stake, seeks to balance power within the alliance.
That has been a stumbling block for other Franco-Italian mergers such as the troubled Essilor-Luxottica tie-up.
The new enterprise will be headquartered in Genoa, with its engineering center based in France’s southern Var region.
Its chief executive Claude Centofanti is a Frenchman and its chairman, Giuseppe Bono, an Italian who is also CEO of Fincantieri.
The two companies have said they will look for efficiencies by taking advantage of their bigger scale, jointly conducting some research and sharing test facilities.
Guillou said the market for mid-size to large frigates was growing 5-7% a year. “It’s also where the emerging competition is attacking us the hardest,” he added.
He said there was potential for Naval Group and the new JV to derive synergies too from the Fincantieri-Chantiers de l’Atlantique tie-up, but a go-ahead from Brussels would be needed before they can be more deeply explored.
But he added that the setting up of the venture and the merger between Fincantieri and Chantier were separate issues, downplaying analysts’ hopes the JV could make it easier to win the go-ahead for Fincantieri-Chantier.
Naval Group holds a minority stake in Chantiers de l’Atlantique.
“We could imagine buying steel benefitting from scale of volume,” Guillou said. “When you think about what vessels of the future might look like, and cleaner energies, it’s not something that will only interest military shipbuilders.”
FILE PHOTO: Jailed Catalan politician Oriol Junqueras attends the first session of parliament following a general election in Madrid, Spain, May 21, 2019. Bernat Armangue/Pool via REUTERS/File Photo
MADRID (Reuters) - Spain’s Supreme Court on Friday blocked Catalan separatist Oriol Junqueras from leaving jail to collect his credentials for the European Parliament, to which he was elected on May 26.
Without the credentials, Junqueras, who is in prison awaiting the conclusion of a high profile trial on Catalonia’s bid for independence from Spain, is unable to claim his seat in the European legislature.
The court said its ruling did not mean he would permanently lose his European seat and that he must remain in jail while it concludes its deliberations surrounding the trial of 12 Catalan political leaders who led the region’s secession push in 2017.
Junqueras had been set to temporarily leave the prison where he has been held since 2017 on Monday to collect the papers.
Catalonia’s independence drive has overshadowed Spanish politics for years and is a major test for Pedro Sanchez’s Socialists after they won a national election in April but fell short of a majority.
Junqueras, the former deputy head of the region, is charged with rebellion, sedition and misuse of public funds for his part in organizing a referendum and declaration of independence that were deemed illegal by Spain’s Constitutional Court. He denies the charges.
Two other Catalan politicians won European Parliament seats in May but have also been unable to formalize their places because they will be detained if they return to Spain to collect their MEP papers.
The region’s former leader Carles Puigdemont and local council member Antoni Comin have both lived in self-imposed exile in Belgium since arrest warrants were issued following the attempted secession.
Junqueras was allowed to leave jail in May to collect his credentials as a member of Spain’s lower house of parliament following April’s election although he will not be able to serve as a lawmaker until the trial is concluded.
Reporting by Belen Carreno; Writing by Paul Day; Editing by Jesus Aguado and Catherine Evans
(Reuters) - Flesh-eating zombies terrorize a small town in Jim Jarmusch’s “The Dead Don’t Die”, a comedy horror in which polar fracking sets off strange reactions and raises the dead.
72nd Cannes Film Festival - Photocall for the film "The Dead Don't Die" in competition - Cannes, France, May 15, 2019. Cast members Bill Murray, Chloe Sevigny, Selena Gomez and Tilda Swinton pose. REUTERS/Stephane Mahe
Reuters spoke with Bill Murray and Chloe Sevigny, who portray police, and Tilda Swinton, who plays a mysterious funeral parlor worker, about the film’s albeit lighthearted environmentalism.
Below are edited excerpts.
TILDA SWINTON
Q: Why is environmentalism such a key theme here?
A: “It’s the landscape of the film, it very often is in zombie films ... (they) are a very useful kind of Trojan Horse to talk about society’s relationship with itself and the environment. But I would say it’s whatever anybody sees in it and this is a landscape that really concerns Jim and all of us.”
Q: What do you do personally to be environmentally friendly?
A: “I would like to fly a great deal less. I think we should all fly less anyway for about a million different reasons and not only to do with the effect of it on our planet but also on our bodies.”
BILL MURRAY
Q: What do you do to be environmentally friendly?
A: “I’m no hero but I tried to give up plastic bottles about three or four years ago. I think I’ve had about four since the situation arose, I either had to take medicine or something like that ... I realized I was drinking probably 100 plastic bottles of water a month. I thought, well, that’s 1,200 a year, at least. And that’s one person. So I gave up and stopped it and I find that glass bottle water tastes better.”
CHLOE SEVIGNY
Q: As someone associated with fashion, what do you do for the environment?
A: “I try not to use any single-use plastic and not use the dryer, take quick showers. It’s all the little things that one can do one hopes will accumulate in some way.
“Flying is always one of the worst and that’s unfortunately unavoidable in my line of work but I do compost in Manhattan and buy mostly recycled clothes. I’m trying to just not consume as much as maybe I have in the past and just try and spread that word to especially young girls. I’m somewhat of a fashion icon and I try encourage people to buy vintage or buy slightly used.”
Reporting by Hanna Rantala; writing by Marie-Louise Gumuchian; editing by Jason Neely
LONDON (Reuters) - Boris Johnson, who has pledged to deliver Brexit on Oct. 31, surged closer to power on Thursday, winning by far the most support from Conservative lawmakers in the first round of the contest to replace Prime Minister Theresa May.
Three years since voting 52%-48% to leave the European Union, the United Kingdom is heading toward a possible crisis over Brexit as most of the candidates vying to succeed May are prepared to leave on Oct. 31 without a deal.
While parliament has indicated it will try to stop a no-deal Brexit, which investors warn would hurt financial markets and the world economy, some of those running say it may be the only way for Britain to leave the bloc without further delay.
Johnson, the face of the official campaign to leave the European Union in the 2016 referendum, won the support of 114 Conservative lawmakers in the first round of the contest to replace May. A total of 313 lawmakers voted.
“Thank you to my friends and colleagues in the Conservative & Unionist Party for your support. I am delighted to win the first ballot, but we have a long way to go,” Johnson said on Twitter.
His closest rivals were: Jeremy Hunt, the foreign minister, who won 43 votes; Michael Gove, environment minister, with 37 votes and Dominic Raab, former Brexit minister, on 27 votes.
Sajid Javid, interior minister, came fifth with 23 votes. Matt Hancock won 20 votes and Rory Stewart 19. Three were knocked out: former leader of the House of Commons Andrea Leadsom, Mark Harper and Esther McVey.
Betting markets give Johnson, who has a long record of scandals and gaffes, a 70% probability of winning the top job.
SECOND ROUND
Johnson, a former London mayor and foreign minister, has spent weeks wooing Conservative lawmakers, staying out of the spotlight with a low-key campaign at odds with his flamboyant publicity stunts of the past.
But his spokesman, while celebrating a higher-than-expected number of supporters, said there was still “a long way to go in the contest and you have to hold the numbers to go into the next rounds and that’s the challenge”.
The second round is due on June 18 with further ballots planned for June 19 and June 20 until there are just two candidates. A postal ballot of the wider Conservative Party membership will then be held to pick a leader.
A new prime minister should be chosen by the end of July. There had been speculation that the contest could be accelerated due to Johnson’s strong lead but there was no immediate sign of rivals bowing out of the race.
Some were quick to make veiled warnings about the frontrunner.
PM hopeful Boris Johnson leaves his home in London, Britain, June 13, 2019. REUTERS/Simon Dawson
Hunt, who has pitched himself as a unifier of both Brexit-supporting and pro-EU Conservatives, warned members of the party that “the stakes have rarely been higher for our country”. “This serious moment calls for a serious leader,” he tweeted.
Stewart, who has criticized Johnson for making promises on Brexit he cannot keep, voiced optimism about his campaign: “This is amazing - we’re getting some real momentum here ... It’s increasingly clear it’s me against Boris. And let’s win.”
Finance minister Philip Hammond, who has not publicly endorsed a candidate, wrote on Thursday to all remaining leadership contenders to urge them to stick to existing budget rules until at least the next scheduled election in 2022.
Johnson has proposed cutting income tax to 20% from 40% for those earning 50,000-80,000 pounds ($65,000-$105,000), while Gove has suggested replacing value-added tax on goods and services with a narrower sales tax.
Johnson kicked off his official campaign on Wednesday with a pledge to lead Britain out of the European Union on Oct. 31 and a warning to his divided Conservative Party that “delay means defeat”.
“After three years and two missed deadlines, we must leave the EU on October 31,” Johnson, 54, said then. “I am not aiming for a no-deal outcome.”
Johnson, whose unconventional style has helped him shrug off a series of scandals in the past, has won over much of his party by arguing that only he can rescue the Conservatives by delivering Brexit.
He argues that if Britain is prepared for a no-deal Brexit, the EU will bend to his argument to remove the so-called Northern Irish backstop to prevent a return to a hard border with Ireland if there is no agreed future trade deal.
Slideshow (3 Images)
But the EU has refused to renegotiate the Withdrawal Agreement reached with May last November and Ireland has said it is not willing to change the backstop.
On Wednesday, the European Commission said: “In light of the continued uncertainty in the United Kingdom ... and the overall domestic political situation, a ‘no-deal’ scenario on 1 November 2019 very much remains a possible - although undesirable - outcome.”
Additional reporting by David Milliken; Writing by Guy Faulconbridge and Elizabeth Piper; Editing by Stephen Addison and Janet Lawrence
LONDON (Reuters) - Britain’s special forces are about to shift away from counter-terrorism work and instead concentrate on blocking covert operations by countries such as Russia, the BBC reported on Thursday, citing unnamed British officials and military sources.
Senior military officers are considering the proposal and are likely to recommend the government approve it, the BBC’s security editor said.
“The counter-terrorist task is drawing down, while the need to confront dangerous international behavior by peer adversaries is increasing,” the BBC quoted one source as saying.
Britain blames Russia’s GRU military intelligence agency for the poison attack on former Russian double agent Sergei Skripal and his daughter Yulia in the English city of Salisbury last year. Russia denies responsibility.
The Skripals’ poisoning with a nerve agent prompted a wave of diplomatic expulsions and recriminations, with ties between London and Moscow shriveling to a post-Cold War low in its wake.
Russia has raised international concerns following its 2014 annexation of Crimea, the Skripal affair and accusations by the United States and some EU governments that it interfered in their elections.
“Under the new plan, an operation might be mounted in a Baltic republic or African country in order to uncover and pinpoint Russian covert activities,” the BBC said.
Britain’s Ministry of Defence declined to comment on the BBC report, and a spokeswoman said the government did not routinely comment on matters affecting special forces.
The BBC said the change would boost the role of Britain’s Special Reconnaissance Regiment, a military unit which carries out covert surveillance such as planting cameras in insurgent-held territory and electronic eavesdropping.
It quoted an unnamed senior British military officer as saying commanders wanted a greater range of options beyond conventional military action.
“Right now, you do nothing or you escalate,” the officer said. “We want to expand that competitive space.”
Reporting by David Milliken; Editing by Sandra Maler
LONDON (Reuters) - Pop singer Robbie Williams, a judge on Britain’s “The X Factor” television show last year, is taking a stake in a performing arts college as he looks to mentor more “jazz hand people” like him.
The singer of “Angels” and “Let Me Entertain You” will have a 20% stake in Liverpool’s LMA, which offers degrees in music, performing arts and games design.
Williams, who hails from Stoke-on-Trent, a city 56 miles (90 km) southeast of Liverpool, mentored a choir from LMA on “The X Factor” last year and said he really enjoyed the experience.
“I was looking into the eyes of all the students and I was like ‘They are me. That’s who I was and who I am’, you know, we sort of ‘jazz hand people’,” the 45-year-old singer told a news conference.
“It’s just that energy that I wanted more of and also I don’t mind saying I was surprised I was actually quite good at mentoring. It’s something that I want to carry on, in whatever capacity that is. I loved it.”
LMA’s plans include opening a new London campus next year.
Williams, a member of popular 1990s boyband Take That, will help drive LMA’s expansion in Britain and abroad.
“I’ll find out more as we go along. But I want to mentor. I want to be there. I want to find out how to teach ... I have a bit of experience in the business.”
Williams, whose wife Ayda Field was also a judge on “The X Factor” alongside series creator Simon Cowell, is working on an album and will not return to the show this year.
Slideshow (2 Images)
“I’m going to be all over the place promoting that. We wanted it desperately to work with ‘The X Factor’ but it just wasn’t (to be),” he said.
“It’s a to-be-continued because myself and Simon are good friends, our family are good friends, the kids hang out all of the time and I think it’s just a pause on the relationship,” Williams said.
“This year I’ve got to go and promote my album to death. So that’s what I’ll be doing.”
Reporting by Hanna Rantala; writing by Marie-Louise Gumuchian; editing by Jason Neely
AMSTERDAM (Reuters) - Dutch health technology company Philips expects sales at its digital care business to grow this year as patients see the benefits of sharing more medical data with doctors, Chief Executive Frans van Houten told Reuters.
FILE PHOTO: CEO Frans van Houten from the Dutch health technology company Philips presents the company's financial results for the fourth quarter and full year 2018, in Amsterdam, Netherlands, January 29, 2019. REUTERS/Eva Plevier
Philips’ connected care division offers platforms to remotely monitor patients and for doctors to share patient data.
“We expect to see a positive trend in connected care this year, with sales growth picking up,” Van Houten said in an interview.
Its sales have lagged those of the company’s bigger divisions, which sell large medical equipment and personal care devices, stagnating in 2018 and falling 1% in the first quarter of 2019.
But Philips, which has spun off its lighting and consumer electronics divisions and now focuses purely on healthcare, expects rising life expectancy and associated chronic diseases to lead to growing demand for devices that allow patients to stay at home, while being monitored.
That view was supported by an international study, published this week, which showed patients with access to their digital health records are more satisfied with the care they receive and are very willing to share that data with doctors.
The study, which involved 15,000 patients and 3,100 doctors across 15 countries and was commissioned by Philips, also showed that two thirds of people who don’t have access to their own records want doctors and other health professionals to have access to their data.
Some 70% of the doctors interviewed with access to digital records said it improved their work.
“Data is the new gold”, Van Houten said. “We are absolutely convinced that sharing more data leads to better diagnosis, better treatment and better outcomes, improving the productivity of doctors.”
Increasing use of digital records could help Philips, as it sells software tools for doctors to gather data from records and devices that allow patients to collect health data, such as blood pressure and cholesterol levels, at home and immediately share them with doctors.
“People want their data to be used”, Van Houten said. “Although the general perception seems to be of an aversion towards data sharing, we actually see the opposite when it comes to health care.”
Reporting by Bart Meijer. Editing by Jane Merriman and Mark Potter
(Reuters) - British drugmaker GSK said it has struck a research deal with the early pioneers of a prominent gene-editing technology at the University of California, in a boost to its prospects for developing new drugs.
GlaxoSmithKline, Britain’s largest drugmaker, will pay up to $67 million over a five-year period for the new Laboratory for Genomics Research, which will be jointly run with the University of California and led by researchers such as Jennifer Doudna, a co-inventor of the CRISPR gene-editing technology.
New gene editing tools - with CRISPR/Cas9 as the most prominent example - have thrown the door wide open for rearranging the genetic code much more precisely and at lower costs than previously possible.
The technology made headlines last year when a Chinese scientist caused outrage with a claim to have “gene-edited” babies, but CRISPR/Cas9 can also be used in medical and agricultural research without interfering with the human germline.
CRISPR works as a molecular scissors that can trim away unwanted pieces of genetic material and replace them with new ones. Easier to use than older techniques, it has quickly become a preferred method of gene editing in research labs.
The new GSK lab will run tests on various irregularities in the human genome and track the malfunctions they trigger in cells, hoping to gain a clearer understanding of the causes of cancer as well as neurological and immunological diseases.
“Once we understand how that changes its function, we can think about how to mitigate that functional impairment and normalize the cell, and normalize, hopefully, the patient by just developing a drug that could prevent them from developing the disease,” said GSK’s Chief Scientific Officer Hal Barron.
GSK, which had hired Barron from Alphabet-backed biotech firm Calico in 2017, will become more dependent on its drug development fortunes as it prepares to fold its consumer health business into a joint venture with Pfizer that will be separately listed.
Automation and heavy-duty computing will allow researchers to analyze hundreds of millions of genetic combinations per experiment at the new lab, Barron added.
The University of California in February scored a victory in a drawn-out legal battle with the Cambridge, Massachusetts-based Broad Institute over the CRISPR patent application that Doudna filed together with Emmanuelle Charpentier of the University of Vienna in 2012.
The new lab in San Francisco will include facilities for 24 full-time university employees funded by GSK plus up to 14 full-time GSK staff.
Other pharma companies are investing in the new method. Bayer and Vertex Pharmaceuticals have independently established collaborations with CRISPR Therapeutics, a biotech firm working on gene therapies.
For GSK, the California lab project ties in with existing data-driven alliances in genetic research with Alphabet-funded gene testing company 23andMe, or with the UK Biobank, a genetic database project.
Additional reporting by Michael Erman in New York, editing by Deepa Babington
(Reuters) - A David and Goliath battle is brewing in the business of selling prescription medicines for pets, pitching veterinarians against online giants moving into this lucrative corner of the growing market for animal supplies.
Destiny Brown, Dr. Katie Buss, and Kingsley family pose with puppies at the Kings Veterinary Hospital in Loveland, Ohio, U.S., on April 26, 2019. Picture taken on April 26, 2019. Courtesy Jennifer Blodgett/Kings Veterinary Hospital/Handout via REUTERS
Americans spent $72.56 billion last year on their pets, according to American Pet Products Association. Prescription drugs were expected to account for over $10 billion, according to an estimate here from the Federal Trade Commission, and overall pet product sales are expected to keep growing by 4% a year. (Graphic:tmsnrt.rs/2KfxTvy)
With deep discounts and online convenience, Walmart Inc, soon-to-be listed Chewy.com and Amazon.com Inc’s Wag brand have effectively conquered the market for pet food, care products and other supplies, but until now veterinary practices, which both prescribe and sell drugs, have been a major source of prescription medication.
While Amazon so far has shown no interest in that market, Chewy’s and Walmart’s forays into the online pet pharmacy business threaten to change that, prompting veterinary clinics to seek help in defending their turf. Enter Covetrus Inc, Vet Source, which partners with Patterson Companies Inc, and others that offer tools to help vets manage their practices and give customers the convenience they have come to expect from online shopping.
“We started to realize this is what our clients want,” said Stephanie Foster, practice manager at Kings Veterinary Hospital in Loveland, Ohio. “They want to be able to order things at 11 o’ clock at night. They’re used to the Amazon mentality.”
Foster says she began using Covetrus to order drugs and supplies for the practice after it began losing sales of pet food and other products to online retailers. Now, her hospital has a website run by Covetrus under the practice’s name that effectively acts as its online pharmacy.
With that comes software that helps the clinic manage its inventory and track prescriptions, so Foster knows when clients need a refill and for those Covetrus collects a service fee that is a percentage of sales.
Foster said partnering with Covetrus has helped boost overall sales by half over the past three years because it gives clients online convenience, timely reminders and, despite the fees, competitive prices.
“Covetrus now has more leverage with the manufacturers than I will ever have as a small business,” she said. “They’re able to get the manufacturers to agree to instant rebates and they can do flash sales on products and things that we just can’t compete with.”
The company, formed by the combination of medical supply firm Henry Schein’s animal health unit and Vet’s First Choice and listed in February, represents some 100,000 veterinary practices globally. In the United States, 27,000 use some form of its services with over 8,000 - about a quarter of the market - signed up for prescription management, Covetrus says.
HOME TURF ADVANTAGE
PetSmart Inc-backed Chewy.com, whose sales soared from $26 million to $3.5 billion between 2012 and 2018, said in a filing ahead of its New York Stock Exchange debut this month it planned to expand its online pharmacy business launched last year.
The company has yet to update on the pharmacy’s performance and it would not comment for this article, citing the silent period ahead of its stock exchange debut.
Walmart joined the fray last month when it launched its online pet pharmacy WalmartPetRx.com and said it aimed to operate 100 in-store animal clinics by the end of the year.
Analysts say, however, the prescription pet medicine business could prove more challenging than other pet products.
Those who want to buy medication online still need a prescription from a vet and must either email or upload a copy or have the online retailer contact the practice first.
That, analysts say, offers the practices a chance to sell the first batch on site and then direct customers to their own online service.
Kristen Cook, a practice manager at the Belton Veterinary Clinic in Belton, Texas, says their doctors have no obligation to write a prescription for those shopping elsewhere and the clinic’s policy is to handle prescriptions internally.
“It’s not something like I am handing them a piece of paper to take it wherever they want to take it,” Cook said.
The stakes are high.
Cook said that at least half of the clinic’s revenue comes from prescription drug sales.
Nationally, pharmacy sales on average make up about a third of a practice’s revenue, according to Gary Glassman, partner at accounting and financial services firm Burzenski & Company, which serves veterinary practices across the country.
The American Veterinary Medical Association (AVMA) says, however, that 40 states have already adopted laws, regulations or guidelines that specifically or implicitly require veterinarians to provide a written prescription upon request in some circumstances.
To see the summary report from AVMA, please click here here
This means pet owners could fill those prescriptions with Chewy or other online providers, and the market is just too attractive to e-commerce players for the vets and their partners to get complacent, analysts say.
According to a 2018 TD Ameritrade online survey of U.S. millennial pet owners, they were willing to spend up to $2,000 on average if their pet got sick, with dog owners prepared to spend more on their pets than what they expected to spend on their own healthcare.
“People are treating their pets more like people,” William Blair analyst John Kreger said. “Historically ... you’d frankly euthanize the pet when they started to have some of these chronic conditions. That’s just not happening now.”
Reporting by Tamara Mathias and Manas Mishra in Bengaluru, Writing by Patrick Graham; Editing by Tomasz Janowski
LONDON (Reuters) - Britain’s media regulator has given the BBC provisional permission to change its popular iPlayer on-demand platform from a 30-day catch-up service to one where programs are available for 12 months or longer.
Ofcom said the changes would help the BBC stay relevant in the face of changing viewing habits and deliver value to the public, which funds the broadcaster by paying an annual license fee of 154.50 pounds ($196) per household.
It said the changes would pose challenges for other public service broadcasters’ video-on-demand services, and would therefore need to be subject to conditions to mitigate against risks to fair competition.
The BBC launched iPlayer in 2007, offering programs for seven days after broadcast. The viewing window was extended to 30 days in 2014.
Ofcom said it was inviting other views before publishing a final decision by August.
Reporting by Paul Sandle; editing by Stephen Addison
